ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Interestingly, the IM-resistant CML cells harboring BCR-ABL T315I mutation exhibited slow cell proliferation associated with down-regulation of glycolytic pathway and low ROS production [7].